Literature DB >> 19762378

Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies.

S A Quadrelli1, C Alvarez, S C Arce, L Paz, J Sarano, E M Sobrino, J Manni.   

Abstract

Pleuropulmonary manifestations of systemic lupus erythematosus (SLE) have been reported to be of variable prevalence, depending on the diagnostic methods used. The objective of this study was to determine the anatomopathological prevalence and the nature of lung involvement associated with SLE and to define if there were differences in the grade and type of pulmonary involvement in patients who had died at different time periods, before or after 1996. Complete autopsy studies of 90 patients with SLE diagnosis carried out between 1958 and 2006 and their clinical records were studied. All patients fulfilled the American College of Rheumathology (ACR) diagnostic criteria for SLE. Two groups of patients were analyzed: patients who had died before 1996 and those deceased in 1996-2006. Some pleuropulmonary involvement was detected in 97.8% of the autopsies. The most frequent findings were pleuritis (77.8%), bacterial infections (57.8%), primary and secondary alveolar haemorrhages (25.6%), followed by distal airway alterations (21.1%), opportunistic infections (14.4%) and pulmonary thromboembolism (7.8%), both acute and chronic. No cases of acute or chronic lupus pneumonitis were found. Opportunistic lung infections were invasive aspergillosis, disseminated strongyloidiasis, mucormicosis and Pneumocystis carinii. Only three of 23 patients with alveolar haemorrhage showed capillaritis. The four patients with primary pulmonary hypertension (PHT) had plexiform lesions. Deceased patients' age at death (46.09 +/- 11.01 vs 30.3 +/- 11.5 years, P < 0.0001) as well as survival time from diagnosis date (11.8 +/- 11.2 vs 4.4 +/- 4.9 years, P < 0.0001) in the second time period evaluated were significantly higher. However, there were no statistically significant differences in the prevalence of any of the pulmonary manifestations. Sepsis was considered the major cause of death without significant differences in both groups. Our results show that pulmonary manifestations directly caused by systemic lupus erythematosus are very uncommon and that their prevalence has not changed in the past 10 years. Pulmonary infection is still the most frequent affection, and it is an important cause of death in patients with lupus.

Entities:  

Mesh:

Year:  2009        PMID: 19762378     DOI: 10.1177/0961203309106601

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  15 in total

1.  Fulminant antiphospholipid antibody syndrome complicated by Aspergillus tracheobronchitis.

Authors:  Peralam Yegneswaran Prakash; Vinay Pandit; Sugandhi P Rao
Journal:  Med Mycol Case Rep       Date:  2012-10-22

Review 2.  Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis.

Authors:  Tian-Tian Lv; Peng Wang; Shi-Yang Guan; Hong-Miao Li; Xiao-Mei Li; Bin Wang; Hai-Feng Pan
Journal:  Ir J Med Sci       Date:  2017-12-18       Impact factor: 1.568

Review 3.  Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review.

Authors:  Huaxia Yang; Huazhen Liu; Ziyue Zhou; Lidan Zhao; Yunyun Fei; Hua Chen; Fengchun Zhang; Xuan Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-07       Impact factor: 8.667

4.  IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation.

Authors:  Siobhan Smith; Pei Wen Wu; Jane J Seo; Thilini Fernando; Mengyao Jin; Jorge Contreras; Erica N Montano; Joan Ní Gabhann; Kyle Cunningham; Amro Widaa; Eoghan M McCarthy; Eamonn S Molloy; Grainne Kearns; Conor C Murphy; Weiping Kong; Harry Björkbacka; Hardy Kornfeld; Lindsy Forbess; Swamy Venuturupalli; Mariko Ishimori; Daniel Wallace; Michael H Weisman; Caroline A Jefferies
Journal:  JCI Insight       Date:  2018-08-09

Review 5.  Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.

Authors:  Atiya Dhala
Journal:  Clin Dev Immunol       Date:  2012-03-22

6.  Pulmonary manifestations in systemic lupus erythematosus: association with disease activity.

Authors:  Omer S B Alamoudi; Suzan M Attar
Journal:  Respirology       Date:  2015-01-30       Impact factor: 6.424

7.  Strongyloidiasis and diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus.

Authors:  Fernando Gonzalez-Ibarra; Parag Chevli; Lindsey Schachter; Maninder Kaur; Sahar Eivaz-Mohammadi; Basheer Tashtoush; Jioty Matta; Amer K Syed; Valentin Marian
Journal:  Case Rep Med       Date:  2014-06-12

8.  Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort.

Authors:  Javier Narváez; Helena Borrell; Fernando Sánchez-Alonso; Iñigo Rúa-Figueroa; Francisco Javier López-Longo; María Galindo-Izquierdo; Jaime Calvo-Alén; Antonio Fernández-Nebro; Alejandro Olivé; José Luis Andreu; Víctor Martínez-Taboada; Joan Miquel Nolla; José María Pego-Reigosa
Journal:  Arthritis Res Ther       Date:  2018-12-19       Impact factor: 5.156

9.  Non-invasive ventilation in patients with acute lupus pneumonitis: A case report and review of literature.

Authors:  Akashdeep Singh; Rupinder Kaur
Journal:  Lung India       Date:  2012-07

Review 10.  Interstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update.

Authors:  Helmut H Popper
Journal:  Virchows Arch       Date:  2012-12-07       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.